Insulin port device co gets $15m boost:
This article was originally published in Clinica
Executive Summary
Austin, Texas-based Patton Medical Devices is ramping up US sales of its I-Port injection port, after receiving $15m from institutional investors. This brings the total investment in the company to $27m. The company's device incorporates a tube that is inserted into the skin, providing diabetics with a readily available channel for injecting their insulin and reducing the need for repeated piercing of the skin. The port can accommodate 75 injection and be worn for up to 72 hours.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.